Nicotine for pyoderma gangrenosum

Archives of Dermatology

Volumn 134, Issue 9, 1998, Pages 1071-1072

  Wolf, Ronni ^a   Ruocco, Vincenzo ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CIMETIDINE; NICOTINE; PREDNISONE; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; CASE REPORT; COLITIS; COMORBIDITY; CORTICOSTEROID THERAPY; DRUG EFFICACY; HUMAN; IMMUNOTHERAPY; MALE; PRIORITY JOURNAL; PYODERMA GANGRENOSUM;

ADMINISTRATION, CUTANEOUS; ADULT; HUMANS; MALE; NICOTINE; PYODERMA GANGRENOSUM;

EID: 0031681384     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.134.9.1071     Document Type: Article

References (7)

1. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci. 1989;34:1841-1845.
2. Srivastava ED, Russel MAH, Feyerabend C, Williams GT, Masterson JG, Rhodes J. Transdermal nicotine in active colitis. Eur J Gastroenterol Hepatol. 1991;3: 815-818.
3. Pullan RD, Rhodes J, Ganesh S, et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med. 1994;330:811-815.
4. Powell FC, Su D, Perry HO. Pyoderma gangrenosum: classification and management. J Am Acad Dermatol. 1996;34:395-409.
5. Kanekura T, Usuki K, Kanzaki T. Nicotine for pyoderma gangrenosum [letter]. Lancet. 1995;345:1058.
6. Kanekura T, Kanzaki T. Successful treatment of pyoderma gangrenosum with nicotine chewing gum [letter]. J Dermatol. 1995;22:7704-7705.
7. Palmer KJ, Buckley MM, Faulds D. Transdermal nicotine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation. Drugs. 1992;44:498-529.